Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
Conditions:   Advanced Solid Tumors;   Hematologic Neoplasms;   Gastric Cancer;   Ovarian Cancer;   GastroEsophageal Cancer;   HER2-positive Breast Cancer;   HER2-positive Gastric Cancer
Interventions:   Biological: MGD013;   Biological: MGD013 in combination with margetuximab
Sponsor:   MacroGenics
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 18, 2020 / by / in
Comments